SABBY MANAGEMENT, LLC - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 121 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$241,000
-81.7%
70,431
-84.0%
0.03%
-82.3%
Q2 2021$1,320,000
-22.9%
441,473
-16.7%
0.19%
-44.1%
Q1 2021$1,712,000
+5606.7%
530,000
+2255.6%
0.33%
+16550.0%
Q2 2016$30,000
-88.2%
22,500
-25.0%
0.00%
-80.0%
Q3 2015$254,000
+247.9%
30,000
+451.7%
0.01%
+233.3%
Q3 2014$73,000
-92.5%
5,438
-92.2%
0.00%
-95.2%
Q4 2013$967,000
+104.0%
70,000
+139.8%
0.06%
+93.8%
Q2 2013$474,00029,1880.03%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2013
NameSharesValueWeighting ↓
BVF INC/IL 15,232,268$29,094,0002.84%
EcoR1 Capital, LLC 412,000$787,0000.08%
PLATINUM INVESTMENT MANAGEMENT LTD 1,130,432$2,159,0000.05%
ESSEX INVESTMENT MANAGEMENT CO LLC 164,605$314,0000.04%
Clear Harbor Asset Management, LLC 95,630$183,0000.03%
ALGERT GLOBAL LLC 72,556$139,0000.03%
180 WEALTH ADVISORS, LLC 30,000$57,0000.03%
GSA CAPITAL PARTNERS LLP 289,854$554,0000.03%
PRELUDE CAPITAL MANAGEMENT, LLC 85,412$163,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$877,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders